Pacira BioSciences
PCRX
PCRX
218 hedge funds and large institutions have $1.86B invested in Pacira BioSciences in 2019 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more capital invested
Capital invested by funds: $1.57B → $1.86B (+$287M)
4% more funds holding
Funds holding: 210 → 218 (+8)
3.35% more ownership
Funds ownership: 100.25% → 103.6% (+3.3%)
Holders
218
Holding in Top 10
6
Calls
$9.61M
Puts
$7.85M
Top Buyers
| 1 | +$37.9M | |
| 2 | +$30.8M | |
| 3 | +$23.1M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$19.7M |
| 5 |
Millennium Management
New York
|
+$17M |
Top Sellers
| 1 | -$40.8M | |
| 2 | -$37.1M | |
| 3 | -$26.9M | |
| 4 |
Goldman Sachs
New York
|
-$12.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$6.94M |